#1 out of 1
business5h ago
Here are Tuesday's biggest analyst calls: Nvidia, Apple, Micron, Pershing Square, Dell, Occidental & more
- UBS upgrades Vipshop to buy, citing earnings resilience amid muted consumption and fierce e-commerce competition.
- JPMorgan initiates Seaport Therapeutics as overweight with a Dec 2027 target of $42.
- Citi starts Pershing Square with a Buy/High Risk rating and $50 target.
- Stifel upgrades Booz Allen Hamilton to buy from hold on attractive valuation and improving fundamentals.
- JPMorgan upgrades Cognex, Timken and Allient to overweight amid robotics and humanoids exposure.
- Goldman Sachs initiates Hemab Therapeutics as buy with a $36 target.
- UBS raises Micron price target to $1,626 on AI-driven AI memory cycle prospects.
- Rothschild & Co Redburn reiterate Nvidia as buy with target to $300.
- UBS initiates Dave Inc as buy with a $300 price target.
- Morgan Stanley initiates Avalyn Pharma as buy amid a strong biotech pipeline.
- Barclays upgrades Occidental Petroleum to overweight from equal weight.
Vote 0
